A549 cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
IRF2
|
ENSG00000168310.6 | interferon regulatory factor 2 |
STAT2
|
ENSG00000170581.9 | signal transducer and activator of transcription 2 |
IRF8
|
ENSG00000140968.6 | interferon regulatory factor 8 |
IRF1
|
ENSG00000125347.9 | interferon regulatory factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
STAT2 | hg19_v2_chr12_-_56753858_56753930 | 0.94 | 5.3e-03 | Click! |
IRF8 | hg19_v2_chr16_+_85942594_85942635 | -0.58 | 2.2e-01 | Click! |
IRF2 | hg19_v2_chr4_-_185395191_185395340 | 0.31 | 5.5e-01 | Click! |
IRF1 | hg19_v2_chr5_-_131826457_131826514 | 0.24 | 6.5e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_948803 | 105.40 |
ENST00000379389.4
|
ISG15
|
ISG15 ubiquitin-like modifier |
chr10_+_91152303 | 91.36 |
ENST00000371804.3
|
IFIT1
|
interferon-induced protein with tetratricopeptide repeats 1 |
chr11_-_615942 | 65.98 |
ENST00000397562.3
ENST00000330243.5 ENST00000397570.1 ENST00000397574.2 |
IRF7
|
interferon regulatory factor 7 |
chr14_+_94577074 | 61.62 |
ENST00000444961.1
ENST00000448882.1 ENST00000557098.1 ENST00000554800.1 ENST00000556544.1 ENST00000298902.5 ENST00000555819.1 ENST00000557634.1 ENST00000555744.1 |
IFI27
|
interferon, alpha-inducible protein 27 |
chr1_-_27998689 | 52.70 |
ENST00000339145.4
ENST00000362020.4 ENST00000361157.6 |
IFI6
|
interferon, alpha-inducible protein 6 |
chr4_-_169239921 | 48.22 |
ENST00000514995.1
ENST00000393743.3 |
DDX60
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 |
chr21_+_42792442 | 46.21 |
ENST00000398600.2
|
MX1
|
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
chr11_-_615570 | 43.86 |
ENST00000525445.1
ENST00000348655.6 ENST00000397566.1 |
IRF7
|
interferon regulatory factor 7 |
chr10_+_91087651 | 34.90 |
ENST00000371818.4
|
IFIT3
|
interferon-induced protein with tetratricopeptide repeats 3 |
chr10_+_91092241 | 32.63 |
ENST00000371811.4
|
IFIT3
|
interferon-induced protein with tetratricopeptide repeats 3 |
chr1_+_79115503 | 27.23 |
ENST00000370747.4
ENST00000438486.1 ENST00000545124.1 |
IFI44
|
interferon-induced protein 44 |
chr3_-_122283079 | 27.21 |
ENST00000471785.1
ENST00000466126.1 |
PARP9
|
poly (ADP-ribose) polymerase family, member 9 |
chr3_-_122283100 | 26.27 |
ENST00000492382.1
ENST00000462315.1 |
PARP9
|
poly (ADP-ribose) polymerase family, member 9 |
chr2_-_163175133 | 25.85 |
ENST00000421365.2
ENST00000263642.2 |
IFIH1
|
interferon induced with helicase C domain 1 |
chr9_-_32526184 | 25.51 |
ENST00000545044.1
ENST00000379868.1 |
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 |
chr21_+_42798094 | 25.34 |
ENST00000398598.3
ENST00000455164.2 ENST00000424365.1 |
MX1
|
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
chr3_-_122283424 | 25.24 |
ENST00000477522.2
ENST00000360356.2 |
PARP9
|
poly (ADP-ribose) polymerase family, member 9 |
chr9_-_32526299 | 25.12 |
ENST00000379882.1
ENST00000379883.2 |
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 |
chr12_+_113376157 | 22.43 |
ENST00000228928.7
|
OAS3
|
2'-5'-oligoadenylate synthetase 3, 100kDa |
chr12_+_113416191 | 22.43 |
ENST00000342315.4
ENST00000392583.2 |
OAS2
|
2'-5'-oligoadenylate synthetase 2, 69/71kDa |
chr12_+_113376249 | 21.68 |
ENST00000551007.1
ENST00000548514.1 |
OAS3
|
2'-5'-oligoadenylate synthetase 3, 100kDa |
chr2_-_7005785 | 21.08 |
ENST00000256722.5
ENST00000404168.1 ENST00000458098.1 |
CMPK2
|
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial |
chr19_-_17516449 | 20.54 |
ENST00000252593.6
|
BST2
|
bone marrow stromal cell antigen 2 |
chr8_-_145060593 | 19.73 |
ENST00000313059.5
ENST00000524918.1 ENST00000313028.7 ENST00000525773.1 |
PARP10
|
poly (ADP-ribose) polymerase family, member 10 |
chr2_-_191878681 | 18.46 |
ENST00000409465.1
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa |
chr2_-_191878874 | 17.70 |
ENST00000392322.3
ENST00000392323.2 ENST00000424722.1 ENST00000361099.3 |
STAT1
|
signal transducer and activator of transcription 1, 91kDa |
chr1_+_79086088 | 17.66 |
ENST00000370751.5
ENST00000342282.3 |
IFI44L
|
interferon-induced protein 44-like |
chr21_+_42798158 | 16.91 |
ENST00000441677.1
|
MX1
|
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
chr12_+_113416265 | 16.80 |
ENST00000449768.2
|
OAS2
|
2'-5'-oligoadenylate synthetase 2, 69/71kDa |
chr21_+_42798124 | 16.45 |
ENST00000417963.1
|
MX1
|
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
chr14_+_24630465 | 16.10 |
ENST00000557894.1
ENST00000559284.1 ENST00000560275.1 |
IRF9
|
interferon regulatory factor 9 |
chr3_+_122283175 | 15.85 |
ENST00000383661.3
|
DTX3L
|
deltex 3-like (Drosophila) |
chr2_-_231084659 | 15.66 |
ENST00000258381.6
ENST00000358662.4 ENST00000455674.1 ENST00000392048.3 |
SP110
|
SP110 nuclear body protein |
chr3_+_122283064 | 15.29 |
ENST00000296161.4
|
DTX3L
|
deltex 3-like (Drosophila) |
chr7_-_92777606 | 14.85 |
ENST00000437805.1
ENST00000446959.1 ENST00000439952.1 ENST00000414791.1 ENST00000446033.1 ENST00000411955.1 ENST00000318238.4 |
SAMD9L
|
sterile alpha motif domain containing 9-like |
chr11_-_64764435 | 14.75 |
ENST00000534177.1
ENST00000301887.4 |
BATF2
|
basic leucine zipper transcription factor, ATF-like 2 |
chr2_-_231084820 | 14.67 |
ENST00000258382.5
ENST00000338556.3 |
SP110
|
SP110 nuclear body protein |
chr9_-_100881466 | 14.48 |
ENST00000341469.2
ENST00000342043.3 ENST00000375098.3 |
TRIM14
|
tripartite motif containing 14 |
chr12_+_113344811 | 14.22 |
ENST00000551241.1
ENST00000553185.1 ENST00000550689.1 |
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr21_+_42797958 | 13.88 |
ENST00000419044.1
|
MX1
|
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
chr22_+_18632666 | 13.00 |
ENST00000215794.7
|
USP18
|
ubiquitin specific peptidase 18 |
chr10_+_91174486 | 12.44 |
ENST00000416601.1
|
IFIT5
|
interferon-induced protein with tetratricopeptide repeats 5 |
chr2_-_37384175 | 12.42 |
ENST00000411537.2
ENST00000233057.4 ENST00000395127.2 ENST00000390013.3 |
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2 |
chr10_+_91174314 | 12.12 |
ENST00000371795.4
|
IFIT5
|
interferon-induced protein with tetratricopeptide repeats 5 |
chr11_+_313503 | 12.11 |
ENST00000528780.1
ENST00000328221.5 |
IFITM1
|
interferon induced transmembrane protein 1 |
chr11_+_5646213 | 11.17 |
ENST00000429814.2
|
TRIM34
|
tripartite motif containing 34 |
chr2_+_231280954 | 10.86 |
ENST00000409824.1
ENST00000409341.1 ENST00000409112.1 ENST00000340126.4 ENST00000341950.4 |
SP100
|
SP100 nuclear antigen |
chr1_-_89488510 | 10.32 |
ENST00000564665.1
ENST00000370481.4 |
GBP3
|
guanylate binding protein 3 |
chr10_+_91061712 | 10.10 |
ENST00000371826.3
|
IFIT2
|
interferon-induced protein with tetratricopeptide repeats 2 |
chr2_+_231280908 | 9.86 |
ENST00000427101.2
ENST00000432979.1 |
SP100
|
SP100 nuclear antigen |
chr4_-_169401628 | 9.83 |
ENST00000514748.1
ENST00000512371.1 ENST00000260184.7 ENST00000505890.1 ENST00000511577.1 |
DDX60L
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 60-like |
chr4_+_89378261 | 9.68 |
ENST00000264350.3
|
HERC5
|
HECT and RLD domain containing E3 ubiquitin protein ligase 5 |
chr3_+_122399444 | 9.63 |
ENST00000474629.2
|
PARP14
|
poly (ADP-ribose) polymerase family, member 14 |
chr11_-_321050 | 9.36 |
ENST00000399808.4
|
IFITM3
|
interferon induced transmembrane protein 3 |
chr12_+_113344755 | 9.19 |
ENST00000550883.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr12_+_113344582 | 9.00 |
ENST00000202917.5
ENST00000445409.2 ENST00000452357.2 |
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr19_+_10196781 | 8.62 |
ENST00000253110.11
|
C19orf66
|
chromosome 19 open reading frame 66 |
chr4_-_187112626 | 8.56 |
ENST00000596414.1
|
AC110771.1
|
Uncharacterized protein |
chr1_-_89531041 | 8.44 |
ENST00000370473.4
|
GBP1
|
guanylate binding protein 1, interferon-inducible |
chr7_-_92747269 | 8.40 |
ENST00000446617.1
ENST00000379958.2 |
SAMD9
|
sterile alpha motif domain containing 9 |
chr1_+_158979680 | 7.90 |
ENST00000368131.4
ENST00000340979.6 |
IFI16
|
interferon, gamma-inducible protein 16 |
chr2_-_231084617 | 7.77 |
ENST00000409815.2
|
SP110
|
SP110 nuclear body protein |
chr3_-_49851313 | 7.67 |
ENST00000333486.3
|
UBA7
|
ubiquitin-like modifier activating enzyme 7 |
chr11_-_63330842 | 7.40 |
ENST00000255695.1
|
HRASLS2
|
HRAS-like suppressor 2 |
chr13_+_50070491 | 7.25 |
ENST00000496612.1
ENST00000357596.3 ENST00000485919.1 ENST00000442195.1 |
PHF11
|
PHD finger protein 11 |
chr9_+_100174344 | 7.16 |
ENST00000422139.2
|
TDRD7
|
tudor domain containing 7 |
chr19_+_10196981 | 6.97 |
ENST00000591813.1
|
C19orf66
|
chromosome 19 open reading frame 66 |
chr13_+_50070077 | 6.94 |
ENST00000378319.3
ENST00000426879.1 |
PHF11
|
PHD finger protein 11 |
chr17_-_40264321 | 6.71 |
ENST00000430773.1
ENST00000413196.2 |
DHX58
|
DEXH (Asp-Glu-X-His) box polypeptide 58 |
chr11_-_57334732 | 6.70 |
ENST00000526659.1
ENST00000527022.1 |
UBE2L6
|
ubiquitin-conjugating enzyme E2L 6 |
chr4_-_76944621 | 6.66 |
ENST00000306602.1
|
CXCL10
|
chemokine (C-X-C motif) ligand 10 |
chr22_+_36649170 | 6.59 |
ENST00000438034.1
ENST00000427990.1 ENST00000347595.7 ENST00000397279.4 ENST00000433768.1 ENST00000440669.2 |
APOL1
|
apolipoprotein L, 1 |
chr12_+_113416340 | 6.56 |
ENST00000552756.1
|
OAS2
|
2'-5'-oligoadenylate synthetase 2, 69/71kDa |
chr1_+_158979686 | 6.31 |
ENST00000368132.3
ENST00000295809.7 |
IFI16
|
interferon, gamma-inducible protein 16 |
chr9_+_100174232 | 6.25 |
ENST00000355295.4
|
TDRD7
|
tudor domain containing 7 |
chr11_-_57335280 | 6.13 |
ENST00000287156.4
|
UBE2L6
|
ubiquitin-conjugating enzyme E2L 6 |
chr12_-_121477039 | 6.12 |
ENST00000257570.5
|
OASL
|
2'-5'-oligoadenylate synthetase-like |
chr12_-_121476959 | 6.08 |
ENST00000339275.5
|
OASL
|
2'-5'-oligoadenylate synthetase-like |
chr1_+_158979792 | 6.02 |
ENST00000359709.3
ENST00000430894.2 |
IFI16
|
interferon, gamma-inducible protein 16 |
chr19_-_49371711 | 6.02 |
ENST00000355496.5
ENST00000263265.6 |
PLEKHA4
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 4 |
chr2_-_55920952 | 5.92 |
ENST00000447944.2
|
PNPT1
|
polyribonucleotide nucleotidyltransferase 1 |
chr16_+_57023406 | 5.87 |
ENST00000262510.6
ENST00000308149.7 ENST00000436936.1 |
NLRC5
|
NLR family, CARD domain containing 5 |
chr3_-_146262365 | 5.83 |
ENST00000448787.2
|
PLSCR1
|
phospholipid scramblase 1 |
chr15_-_80263506 | 5.75 |
ENST00000335661.6
|
BCL2A1
|
BCL2-related protein A1 |
chr3_+_159706537 | 5.41 |
ENST00000305579.2
ENST00000480787.1 ENST00000466512.1 |
IL12A
|
interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) |
chr17_-_76975925 | 5.37 |
ENST00000591274.1
ENST00000589906.1 ENST00000591778.1 ENST00000589775.2 ENST00000585407.1 ENST00000262776.3 |
LGALS3BP
|
lectin, galactoside-binding, soluble, 3 binding protein |
chr17_-_40264692 | 5.32 |
ENST00000591220.1
ENST00000251642.3 |
DHX58
|
DEXH (Asp-Glu-X-His) box polypeptide 58 |
chr10_-_77161004 | 5.18 |
ENST00000418818.2
|
RP11-399K21.11
|
RP11-399K21.11 |
chr1_-_154580616 | 5.15 |
ENST00000368474.4
|
ADAR
|
adenosine deaminase, RNA-specific |
chr21_+_35107346 | 5.10 |
ENST00000456489.1
|
ITSN1
|
intersectin 1 (SH3 domain protein) |
chr22_+_36649056 | 4.60 |
ENST00000397278.3
ENST00000422706.1 ENST00000426053.1 ENST00000319136.4 |
APOL1
|
apolipoprotein L, 1 |
chr11_+_34663913 | 4.60 |
ENST00000532302.1
|
EHF
|
ets homologous factor |
chr17_+_76311791 | 4.56 |
ENST00000586321.1
|
AC061992.2
|
AC061992.2 |
chr3_-_146262352 | 4.52 |
ENST00000462666.1
|
PLSCR1
|
phospholipid scramblase 1 |
chr2_+_85811525 | 4.37 |
ENST00000306384.4
|
VAMP5
|
vesicle-associated membrane protein 5 |
chr3_-_146262428 | 4.29 |
ENST00000486631.1
|
PLSCR1
|
phospholipid scramblase 1 |
chr2_+_202122826 | 4.10 |
ENST00000413726.1
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase |
chr3_-_146262293 | 4.05 |
ENST00000448205.1
|
PLSCR1
|
phospholipid scramblase 1 |
chr15_+_45003675 | 4.03 |
ENST00000558401.1
ENST00000559916.1 ENST00000544417.1 |
B2M
|
beta-2-microglobulin |
chr15_+_89182178 | 3.88 |
ENST00000559876.1
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr17_+_41158742 | 3.84 |
ENST00000415816.2
ENST00000438323.2 |
IFI35
|
interferon-induced protein 35 |
chr8_+_27184320 | 3.70 |
ENST00000522517.1
|
PTK2B
|
protein tyrosine kinase 2 beta |
chr11_-_104905840 | 3.69 |
ENST00000526568.1
ENST00000393136.4 ENST00000531166.1 ENST00000534497.1 ENST00000527979.1 ENST00000446369.1 ENST00000353247.5 ENST00000528974.1 ENST00000533400.1 ENST00000525825.1 ENST00000436863.3 |
CASP1
|
caspase 1, apoptosis-related cysteine peptidase |
chr12_-_8693469 | 3.65 |
ENST00000545274.1
ENST00000446457.2 |
CLEC4E
|
C-type lectin domain family 4, member E |
chr3_-_146262488 | 3.64 |
ENST00000487389.1
|
PLSCR1
|
phospholipid scramblase 1 |
chr6_+_126240442 | 3.64 |
ENST00000448104.1
ENST00000438495.1 ENST00000444128.1 |
NCOA7
|
nuclear receptor coactivator 7 |
chr11_-_4414880 | 3.61 |
ENST00000254436.7
ENST00000543625.1 |
TRIM21
|
tripartite motif containing 21 |
chr11_-_14358620 | 3.56 |
ENST00000531421.1
|
RRAS2
|
related RAS viral (r-ras) oncogene homolog 2 |
chr1_-_150693318 | 3.45 |
ENST00000442853.1
ENST00000368995.4 ENST00000368993.2 ENST00000361824.2 ENST00000322343.7 |
HORMAD1
|
HORMA domain containing 1 |
chr3_-_28390120 | 3.42 |
ENST00000334100.6
|
AZI2
|
5-azacytidine induced 2 |
chr12_-_10324716 | 3.40 |
ENST00000545927.1
ENST00000432556.2 ENST00000309539.3 ENST00000544577.1 |
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1 |
chr14_+_24605389 | 3.36 |
ENST00000382708.3
ENST00000561435.1 |
PSME1
|
proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) |
chr3_-_146262637 | 3.36 |
ENST00000472349.1
ENST00000342435.4 |
PLSCR1
|
phospholipid scramblase 1 |
chr15_+_89182156 | 3.35 |
ENST00000379224.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr3_+_122399697 | 3.25 |
ENST00000494811.1
|
PARP14
|
poly (ADP-ribose) polymerase family, member 14 |
chr12_-_12715266 | 3.15 |
ENST00000228862.2
|
DUSP16
|
dual specificity phosphatase 16 |
chr6_+_26440700 | 3.14 |
ENST00000494393.1
ENST00000482451.1 ENST00000244519.2 ENST00000339789.4 ENST00000471353.1 ENST00000361232.3 ENST00000487627.1 ENST00000496719.1 ENST00000490254.1 ENST00000487272.1 |
BTN3A3
|
butyrophilin, subfamily 3, member A3 |
chr10_-_18948208 | 3.08 |
ENST00000607346.1
|
ARL5B-AS1
|
ARL5B antisense RNA 1 |
chr20_-_47894569 | 3.06 |
ENST00000371744.1
ENST00000371752.1 ENST00000396105.1 |
ZNFX1
|
zinc finger, NFX1-type containing 1 |
chr17_-_54991395 | 2.95 |
ENST00000316881.4
|
TRIM25
|
tripartite motif containing 25 |
chr6_+_32821924 | 2.93 |
ENST00000374859.2
ENST00000453265.2 |
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9 |
chr17_+_6659153 | 2.92 |
ENST00000441631.1
ENST00000438512.1 ENST00000346752.4 ENST00000361842.3 |
XAF1
|
XIAP associated factor 1 |
chr17_+_28443819 | 2.92 |
ENST00000479218.2
|
NSRP1
|
nuclear speckle splicing regulatory protein 1 |
chr12_-_56753858 | 2.91 |
ENST00000314128.4
ENST00000557235.1 ENST00000418572.2 |
STAT2
|
signal transducer and activator of transcription 2, 113kDa |
chr17_-_54991369 | 2.89 |
ENST00000537230.1
|
TRIM25
|
tripartite motif containing 25 |
chr5_-_96143796 | 2.86 |
ENST00000296754.3
|
ERAP1
|
endoplasmic reticulum aminopeptidase 1 |
chr6_+_32811885 | 2.81 |
ENST00000458296.1
ENST00000413039.1 ENST00000429600.1 ENST00000412095.1 ENST00000415067.1 ENST00000395330.1 |
TAPSAR1
PSMB9
|
TAP1 and PSMB8 antisense RNA 1 proteasome (prosome, macropain) subunit, beta type, 9 |
chr8_+_107630340 | 2.75 |
ENST00000497705.1
|
OXR1
|
oxidation resistance 1 |
chr14_+_24605361 | 2.69 |
ENST00000206451.6
ENST00000559123.1 |
PSME1
|
proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) |
chr12_-_8693539 | 2.67 |
ENST00000299663.3
|
CLEC4E
|
C-type lectin domain family 4, member E |
chr15_+_89181974 | 2.66 |
ENST00000306072.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr4_+_26165074 | 2.65 |
ENST00000512351.1
|
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region |
chr10_-_18948156 | 2.65 |
ENST00000414939.1
ENST00000449529.1 ENST00000456217.1 ENST00000444660.1 |
ARL5B-AS1
|
ARL5B antisense RNA 1 |
chr7_-_102985288 | 2.60 |
ENST00000379263.3
|
DNAJC2
|
DnaJ (Hsp40) homolog, subfamily C, member 2 |
chr6_+_32811861 | 2.59 |
ENST00000453426.1
|
TAPSAR1
|
TAP1 and PSMB8 antisense RNA 1 |
chr3_+_97483572 | 2.58 |
ENST00000335979.2
ENST00000394206.1 |
ARL6
|
ADP-ribosylation factor-like 6 |
chr22_+_36044411 | 2.55 |
ENST00000409652.4
|
APOL6
|
apolipoprotein L, 6 |
chr15_+_75491203 | 2.54 |
ENST00000562637.1
|
C15orf39
|
chromosome 15 open reading frame 39 |
chr15_+_78832747 | 2.53 |
ENST00000560217.1
ENST00000044462.7 ENST00000559082.1 ENST00000559948.1 ENST00000413382.2 ENST00000559146.1 ENST00000558281.1 |
PSMA4
|
proteasome (prosome, macropain) subunit, alpha type, 4 |
chr20_-_5100591 | 2.48 |
ENST00000379143.5
|
PCNA
|
proliferating cell nuclear antigen |
chr14_+_58711539 | 2.48 |
ENST00000216455.4
ENST00000412908.2 ENST00000557508.1 |
PSMA3
|
proteasome (prosome, macropain) subunit, alpha type, 3 |
chr12_-_10022735 | 2.48 |
ENST00000228438.2
|
CLEC2B
|
C-type lectin domain family 2, member B |
chr9_-_33402506 | 2.44 |
ENST00000377425.4
ENST00000537089.1 ENST00000297988.1 ENST00000539936.1 ENST00000541274.1 |
AQP7
|
aquaporin 7 |
chr6_-_31324943 | 2.44 |
ENST00000412585.2
ENST00000434333.1 |
HLA-B
|
major histocompatibility complex, class I, B |
chr5_+_96211643 | 2.41 |
ENST00000437043.3
ENST00000510373.1 |
ERAP2
|
endoplasmic reticulum aminopeptidase 2 |
chr4_-_130014729 | 2.39 |
ENST00000281142.5
ENST00000434680.1 |
SCLT1
|
sodium channel and clathrin linker 1 |
chr5_-_39203093 | 2.37 |
ENST00000515010.1
|
FYB
|
FYN binding protein |
chr1_-_150693305 | 2.37 |
ENST00000368987.1
|
HORMAD1
|
HORMA domain containing 1 |
chr1_+_110453109 | 2.31 |
ENST00000525659.1
|
CSF1
|
colony stimulating factor 1 (macrophage) |
chr2_+_231191875 | 2.30 |
ENST00000444636.1
ENST00000415673.2 ENST00000243810.6 ENST00000396563.4 |
SP140L
|
SP140 nuclear body protein-like |
chr1_-_114430169 | 2.27 |
ENST00000393316.3
|
BCL2L15
|
BCL2-like 15 |
chr1_-_24469602 | 2.27 |
ENST00000270800.1
|
IL22RA1
|
interleukin 22 receptor, alpha 1 |
chrX_+_54947229 | 2.25 |
ENST00000442098.1
ENST00000430420.1 ENST00000453081.1 ENST00000173898.7 ENST00000319167.8 ENST00000375022.4 ENST00000399736.1 ENST00000440072.1 ENST00000420798.2 ENST00000431115.1 ENST00000440759.1 ENST00000375041.2 |
TRO
|
trophinin |
chr1_-_60392452 | 2.24 |
ENST00000371204.3
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2 |
chrX_-_119693745 | 2.24 |
ENST00000371323.2
|
CUL4B
|
cullin 4B |
chr15_+_74287035 | 2.20 |
ENST00000395132.2
ENST00000268059.6 ENST00000354026.6 ENST00000268058.3 ENST00000565898.1 ENST00000569477.1 ENST00000569965.1 ENST00000567543.1 ENST00000436891.3 ENST00000435786.2 ENST00000564428.1 ENST00000359928.4 |
PML
|
promyelocytic leukemia |
chr3_-_167452262 | 2.17 |
ENST00000487947.2
|
PDCD10
|
programmed cell death 10 |
chr9_+_108424738 | 2.16 |
ENST00000334077.3
|
TAL2
|
T-cell acute lymphocytic leukemia 2 |
chr9_-_107754034 | 2.15 |
ENST00000457720.1
|
RP11-217B7.3
|
RP11-217B7.3 |
chr3_+_48507210 | 2.15 |
ENST00000433541.1
ENST00000422277.2 ENST00000436480.2 ENST00000444177.1 |
TREX1
|
three prime repair exonuclease 1 |
chr6_-_113953705 | 2.14 |
ENST00000452675.1
|
RP11-367G18.1
|
RP11-367G18.1 |
chr7_-_30066233 | 2.14 |
ENST00000222803.5
|
FKBP14
|
FK506 binding protein 14, 22 kDa |
chr19_+_11708229 | 2.13 |
ENST00000361113.5
|
ZNF627
|
zinc finger protein 627 |
chr11_+_46402297 | 2.09 |
ENST00000405308.2
|
MDK
|
midkine (neurite growth-promoting factor 2) |
chr21_+_37692481 | 2.07 |
ENST00000400485.1
|
MORC3
|
MORC family CW-type zinc finger 3 |
chr12_+_28299014 | 2.04 |
ENST00000538586.1
ENST00000536154.1 |
CCDC91
|
coiled-coil domain containing 91 |
chr6_-_32811771 | 2.04 |
ENST00000395339.3
ENST00000374882.3 |
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8 |
chr11_+_46402744 | 2.03 |
ENST00000533952.1
|
MDK
|
midkine (neurite growth-promoting factor 2) |
chr12_-_62653903 | 2.01 |
ENST00000552075.1
|
FAM19A2
|
family with sequence similarity 19 (chemokine (C-C motif)-like), member A2 |
chr3_-_10028366 | 2.00 |
ENST00000429759.1
|
EMC3
|
ER membrane protein complex subunit 3 |
chr14_-_24615523 | 1.99 |
ENST00000559056.1
|
PSME2
|
proteasome (prosome, macropain) activator subunit 2 (PA28 beta) |
chr11_-_321340 | 1.95 |
ENST00000526811.1
|
IFITM3
|
interferon induced transmembrane protein 3 |
chr3_+_48507621 | 1.95 |
ENST00000456089.1
|
TREX1
|
three prime repair exonuclease 1 |
chr6_+_25963020 | 1.93 |
ENST00000357085.3
|
TRIM38
|
tripartite motif containing 38 |
chr11_+_5710919 | 1.85 |
ENST00000379965.3
ENST00000425490.1 |
TRIM22
|
tripartite motif containing 22 |
chr3_+_164924716 | 1.84 |
ENST00000470138.1
ENST00000498616.1 |
RP11-85M11.2
|
RP11-85M11.2 |
chr12_+_40618764 | 1.83 |
ENST00000343742.2
|
LRRK2
|
leucine-rich repeat kinase 2 |
chr9_+_33264861 | 1.82 |
ENST00000223500.8
|
CHMP5
|
charged multivesicular body protein 5 |
chr4_-_130014532 | 1.80 |
ENST00000506368.1
ENST00000439369.2 ENST00000503215.1 |
SCLT1
|
sodium channel and clathrin linker 1 |
chr14_-_35099315 | 1.76 |
ENST00000396526.3
ENST00000396534.3 ENST00000355110.5 ENST00000557265.1 |
SNX6
|
sorting nexin 6 |
chr19_+_49977466 | 1.74 |
ENST00000596435.1
ENST00000344019.3 ENST00000597551.1 ENST00000204637.2 ENST00000600429.1 |
FLT3LG
|
fms-related tyrosine kinase 3 ligand |
chr9_+_5450503 | 1.73 |
ENST00000381573.4
ENST00000381577.3 |
CD274
|
CD274 molecule |
chr19_-_50400212 | 1.72 |
ENST00000391826.2
|
IL4I1
|
interleukin 4 induced 1 |
chr6_-_8102714 | 1.72 |
ENST00000502429.1
ENST00000429723.2 ENST00000507463.1 ENST00000379715.5 |
EEF1E1
|
eukaryotic translation elongation factor 1 epsilon 1 |
chr3_+_160822462 | 1.69 |
ENST00000468606.1
ENST00000460503.1 |
NMD3
|
NMD3 ribosome export adaptor |
chr2_+_210288760 | 1.68 |
ENST00000199940.6
|
MAP2
|
microtubule-associated protein 2 |
chr9_+_4985016 | 1.67 |
ENST00000539801.1
|
JAK2
|
Janus kinase 2 |
chr22_+_39417118 | 1.67 |
ENST00000216099.8
|
APOBEC3D
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3D |
chr1_+_186798073 | 1.67 |
ENST00000367466.3
ENST00000442353.2 |
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
chr11_+_308143 | 1.67 |
ENST00000399817.4
|
IFITM2
|
interferon induced transmembrane protein 2 |
chr6_+_27925019 | 1.67 |
ENST00000244623.1
|
OR2B6
|
olfactory receptor, family 2, subfamily B, member 6 |
chr19_-_18197714 | 1.65 |
ENST00000322153.7
|
IL12RB1
|
interleukin 12 receptor, beta 1 |
chr17_+_57233087 | 1.64 |
ENST00000578777.1
ENST00000577457.1 ENST00000582995.1 |
PRR11
|
proline rich 11 |
chr11_+_34642656 | 1.64 |
ENST00000257831.3
ENST00000450654.2 |
EHF
|
ets homologous factor |
chr2_-_99485825 | 1.64 |
ENST00000423771.1
|
KIAA1211L
|
KIAA1211-like |
chr2_-_162931052 | 1.63 |
ENST00000360534.3
|
DPP4
|
dipeptidyl-peptidase 4 |
chr6_-_32821599 | 1.62 |
ENST00000354258.4
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
chr6_+_29691198 | 1.59 |
ENST00000440587.2
ENST00000434407.2 |
HLA-F
|
major histocompatibility complex, class I, F |
chr2_+_202122703 | 1.59 |
ENST00000447616.1
ENST00000358485.4 |
CASP8
|
caspase 8, apoptosis-related cysteine peptidase |
chr2_-_180871780 | 1.59 |
ENST00000410053.3
ENST00000295749.6 ENST00000404136.2 |
CWC22
|
CWC22 spliceosome-associated protein homolog (S. cerevisiae) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
36.6 | 109.8 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
22.8 | 91.4 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
18.7 | 75.0 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
11.3 | 135.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
10.1 | 60.5 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
9.0 | 36.2 | GO:0046725 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
9.0 | 99.1 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
6.8 | 20.5 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) negative regulation of intracellular transport of viral material(GO:1901253) |
6.0 | 77.6 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
5.5 | 114.7 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
5.3 | 21.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
4.8 | 52.4 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
4.2 | 45.8 | GO:0018377 | protein myristoylation(GO:0018377) |
3.7 | 44.4 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
2.7 | 43.9 | GO:0035455 | response to interferon-alpha(GO:0035455) |
2.6 | 20.7 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
2.6 | 25.7 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
2.0 | 9.9 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
2.0 | 5.9 | GO:2000625 | rRNA import into mitochondrion(GO:0035928) regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
1.9 | 5.8 | GO:0060629 | regulation of homologous chromosome segregation(GO:0060629) |
1.4 | 5.7 | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) |
1.4 | 7.1 | GO:0039507 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
1.4 | 120.5 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
1.2 | 7.4 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
1.2 | 1.2 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
1.1 | 6.9 | GO:0030421 | defecation(GO:0030421) |
1.1 | 7.8 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) |
1.0 | 15.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.9 | 3.7 | GO:0045208 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
0.9 | 3.4 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.8 | 4.1 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
0.8 | 1.6 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.8 | 2.3 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
0.8 | 45.2 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.7 | 0.7 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
0.7 | 16.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.7 | 2.0 | GO:1904604 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
0.6 | 2.6 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.6 | 2.5 | GO:1902990 | leading strand elongation(GO:0006272) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.6 | 3.1 | GO:1903974 | mammary gland fat development(GO:0060611) regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) regulation of response to macrophage colony-stimulating factor(GO:1903969) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) positive regulation of microglial cell migration(GO:1904141) |
0.6 | 1.8 | GO:1903216 | negative regulation of late endosome to lysosome transport(GO:1902823) regulation of protein processing involved in protein targeting to mitochondrion(GO:1903216) negative regulation of protein processing involved in protein targeting to mitochondrion(GO:1903217) |
0.6 | 1.8 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.6 | 4.8 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.6 | 30.7 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.6 | 3.6 | GO:2000538 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.5 | 1.6 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
0.5 | 1.6 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
0.5 | 3.1 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.5 | 14.5 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.5 | 1.9 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.4 | 1.7 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
0.4 | 2.0 | GO:0046292 | spermatid nucleus elongation(GO:0007290) formaldehyde metabolic process(GO:0046292) |
0.4 | 3.7 | GO:0060844 | arterial endothelial cell fate commitment(GO:0060844) |
0.4 | 0.4 | GO:0002856 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
0.4 | 13.4 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.4 | 0.4 | GO:0051595 | response to methylglyoxal(GO:0051595) |
0.4 | 1.4 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.4 | 1.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.3 | 2.4 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.3 | 1.0 | GO:1904253 | lipid transport involved in lipid storage(GO:0010877) positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.3 | 1.7 | GO:1902728 | mineralocorticoid receptor signaling pathway(GO:0031959) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
0.3 | 0.7 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.3 | 1.0 | GO:0019085 | early viral transcription(GO:0019085) |
0.3 | 2.6 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
0.3 | 0.9 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.3 | 2.4 | GO:0015793 | glycerol transport(GO:0015793) |
0.3 | 0.3 | GO:0070316 | regulation of G0 to G1 transition(GO:0070316) positive regulation of G0 to G1 transition(GO:0070318) |
0.3 | 6.4 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.3 | 1.7 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.3 | 1.1 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.3 | 10.5 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.3 | 1.1 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.3 | 1.1 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.2 | 0.2 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.2 | 1.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 1.2 | GO:0043335 | protein unfolding(GO:0043335) |
0.2 | 3.0 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.2 | 0.9 | GO:0035668 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
0.2 | 0.7 | GO:0051795 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) uterine wall breakdown(GO:0042704) positive regulation of catagen(GO:0051795) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) regulation of complement-dependent cytotoxicity(GO:1903659) |
0.2 | 1.3 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.2 | 0.7 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.2 | 1.9 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.2 | 0.8 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.2 | 1.4 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.2 | 1.7 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.2 | 0.9 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 0.6 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.2 | 1.1 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.2 | 5.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.2 | 0.6 | GO:1902868 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
0.2 | 3.0 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.2 | 1.7 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.2 | 0.7 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.2 | 0.5 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.2 | 0.7 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) neuron projection maintenance(GO:1990535) |
0.2 | 0.4 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.2 | 1.7 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.2 | 1.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 2.0 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.2 | 0.8 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.2 | 1.8 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 1.1 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
0.2 | 1.0 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.2 | 0.2 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.2 | 1.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 0.8 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.2 | 1.1 | GO:0051133 | regulation of NK T cell activation(GO:0051133) positive regulation of NK T cell activation(GO:0051135) |
0.2 | 0.9 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.2 | 0.8 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.2 | 1.2 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.2 | 1.8 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.2 | 0.9 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.2 | 0.5 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.1 | 0.6 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.1 | 0.9 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.6 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
0.1 | 0.7 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.1 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.1 | 1.4 | GO:0097338 | response to clozapine(GO:0097338) |
0.1 | 51.1 | GO:0009615 | response to virus(GO:0009615) |
0.1 | 0.7 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 1.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.9 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 0.6 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.1 | 1.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.5 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.1 | 0.9 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 2.0 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 11.8 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.1 | 0.2 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 0.8 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.3 | GO:0035989 | tendon development(GO:0035989) |
0.1 | 0.9 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.1 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 6.9 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.5 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.1 | 0.8 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 1.0 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.3 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.1 | 0.3 | GO:0032661 | central nervous system myelin formation(GO:0032289) regulation of interleukin-18 production(GO:0032661) detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
0.1 | 2.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.3 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.1 | 1.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.1 | 0.7 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 1.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 2.2 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 0.8 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.1 | 1.3 | GO:0006293 | nucleotide-excision repair, preincision complex stabilization(GO:0006293) |
0.1 | 2.7 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.1 | 0.3 | GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.1 | 4.7 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 2.5 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 1.7 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.3 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.1 | 0.3 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.1 | 5.1 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 1.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 1.9 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.1 | 1.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.9 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.1 | 0.7 | GO:0006294 | nucleotide-excision repair, preincision complex assembly(GO:0006294) |
0.1 | 0.5 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
0.1 | 3.9 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.1 | 0.3 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.7 | GO:0060174 | pulmonary myocardium development(GO:0003350) limb bud formation(GO:0060174) |
0.1 | 1.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.4 | GO:0006574 | valine catabolic process(GO:0006574) |
0.1 | 1.5 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.3 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.3 | GO:0002501 | peptide antigen assembly with MHC protein complex(GO:0002501) peptide antigen assembly with MHC class II protein complex(GO:0002503) |
0.1 | 0.7 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 0.2 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) regulation of cholesterol transporter activity(GO:0060694) pancreatic stellate cell proliferation(GO:0072343) regulation of pancreatic stellate cell proliferation(GO:2000229) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.1 | 0.4 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 4.2 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.5 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 0.4 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
0.1 | 0.5 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 1.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.4 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.1 | 0.9 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.2 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 1.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 0.9 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 0.3 | GO:0044254 | angiotensin catabolic process in blood(GO:0002005) multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) |
0.1 | 0.8 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 0.2 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.3 | GO:0072319 | vacuolar transmembrane transport(GO:0034486) late endosomal microautophagy(GO:0061738) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) clathrin coat disassembly(GO:0072318) vesicle uncoating(GO:0072319) negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
0.1 | 0.7 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 1.9 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.1 | 0.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.8 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.4 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
0.1 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.8 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.1 | 1.6 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.9 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.1 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.0 | 0.4 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 4.8 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
0.0 | 1.8 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.0 | 0.3 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.8 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.0 | 0.2 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.0 | 0.5 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.0 | 0.1 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.0 | 2.4 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.6 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.4 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.0 | 0.4 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
0.0 | 0.1 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
0.0 | 1.0 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.0 | 0.2 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.4 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.0 | 0.1 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.0 | 0.2 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.0 | 1.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.4 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.4 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.0 | 0.2 | GO:1990523 | bone regeneration(GO:1990523) |
0.0 | 0.3 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.0 | 0.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.1 | GO:0070904 | L-ascorbic acid transport(GO:0015882) molecular hydrogen transport(GO:0015993) transepithelial L-ascorbic acid transport(GO:0070904) |
0.0 | 0.7 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 | 0.9 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.0 | 1.5 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.0 | 2.4 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.5 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.5 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.0 | 0.1 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
0.0 | 0.1 | GO:0033385 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
0.0 | 1.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.4 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.0 | 0.3 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.8 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.5 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.9 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.1 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.0 | 0.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.3 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.0 | 0.3 | GO:0048593 | camera-type eye morphogenesis(GO:0048593) |
0.0 | 0.6 | GO:0009409 | response to cold(GO:0009409) |
0.0 | 0.4 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.3 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.0 | 0.2 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.0 | 0.3 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.0 | GO:0048865 | ganglion mother cell fate determination(GO:0007402) stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.0 | 1.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.3 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.9 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 1.2 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.4 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 3.5 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 1.5 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.0 | 2.7 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.2 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.0 | 0.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.7 | GO:0071711 | basement membrane organization(GO:0071711) |
0.0 | 0.5 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.0 | 0.4 | GO:0006833 | water transport(GO:0006833) |
0.0 | 0.1 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.0 | 0.2 | GO:0071910 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
0.0 | 4.3 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 | 0.3 | GO:0015866 | ADP transport(GO:0015866) |
0.0 | 0.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.3 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.4 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.0 | 0.1 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.0 | 0.2 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.0 | 1.0 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.1 | GO:0061462 | protein targeting to lysosome(GO:0006622) protein localization to lysosome(GO:0061462) |
0.0 | 0.1 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.6 | GO:0010470 | regulation of gastrulation(GO:0010470) |
0.0 | 0.2 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.0 | 0.3 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 1.7 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.1 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.0 | 0.1 | GO:0051972 | regulation of telomerase activity(GO:0051972) |
0.0 | 0.3 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.5 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 1.5 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.0 | 0.4 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.9 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.0 | 0.2 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.0 | 1.0 | GO:0048477 | oogenesis(GO:0048477) |
0.0 | 0.6 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.0 | 0.2 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.0 | 0.4 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.0 | 0.2 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.1 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.0 | 0.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.1 | GO:0046034 | ATP metabolic process(GO:0046034) |
0.0 | 0.1 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.0 | 0.1 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.1 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.0 | 0.5 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.1 | GO:0035799 | ureter maturation(GO:0035799) |
0.0 | 0.5 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.0 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 21.1 | GO:0030870 | Mre11 complex(GO:0030870) |
1.6 | 9.6 | GO:0008537 | proteasome activator complex(GO:0008537) |
1.1 | 23.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.9 | 4.7 | GO:0031905 | early endosome lumen(GO:0031905) |
0.9 | 5.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.8 | 2.5 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.7 | 3.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.7 | 13.0 | GO:0033391 | chromatoid body(GO:0033391) |
0.6 | 79.2 | GO:0043657 | host(GO:0018995) host cell(GO:0043657) |
0.6 | 5.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.6 | 7.0 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.6 | 2.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.5 | 1.6 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.5 | 60.4 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.5 | 2.6 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.5 | 3.1 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.5 | 1.9 | GO:0031213 | RSF complex(GO:0031213) |
0.5 | 1.8 | GO:0044753 | amphisome(GO:0044753) |
0.4 | 12.5 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.4 | 1.2 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.4 | 1.6 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.3 | 2.6 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 20.9 | GO:0005771 | multivesicular body(GO:0005771) |
0.3 | 1.9 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.3 | 4.4 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.3 | 126.1 | GO:0031965 | nuclear membrane(GO:0031965) |
0.3 | 2.9 | GO:0031906 | late endosome lumen(GO:0031906) |
0.3 | 2.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 2.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 1.2 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.2 | 0.9 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 0.2 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.2 | 46.9 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 3.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 1.7 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.2 | 46.6 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.2 | 1.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 1.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 1.3 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.2 | 1.0 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 0.7 | GO:0070985 | TFIIK complex(GO:0070985) |
0.2 | 1.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 1.1 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.2 | 110.0 | GO:0010008 | endosome membrane(GO:0010008) |
0.2 | 1.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 12.1 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 2.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 2.0 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 1.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 2.0 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 1.7 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.1 | 4.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.8 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 5.8 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 0.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 1.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 0.4 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.1 | 0.8 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 1.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.6 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 1.8 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 0.7 | GO:0001741 | XY body(GO:0001741) |
0.1 | 1.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.3 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.1 | 0.6 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.4 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.1 | 0.4 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 0.2 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 1.5 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 2.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 1.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 233.9 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.6 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.8 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 1.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.2 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.1 | 1.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 0.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 5.0 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.8 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 0.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.8 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 1.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.8 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 30.1 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 1.3 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.1 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 0.4 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 1.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 8.5 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 3.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 9.8 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 198.3 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 1.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.4 | GO:0071953 | elastic fiber(GO:0071953) |
0.0 | 2.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.1 | GO:0097444 | spine apparatus(GO:0097444) |
0.0 | 1.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 20.8 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 1.4 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 2.3 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 1.6 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.4 | GO:0033269 | internode region of axon(GO:0033269) |
0.0 | 0.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.1 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 0.1 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.0 | 0.8 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 0.1 | GO:0070703 | inner mucus layer(GO:0070702) outer mucus layer(GO:0070703) |
0.0 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.5 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.3 | GO:0035580 | specific granule lumen(GO:0035580) |
0.0 | 0.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.4 | GO:0034399 | nuclear matrix(GO:0016363) nuclear periphery(GO:0034399) |
0.0 | 3.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.2 | GO:1990752 | microtubule end(GO:1990752) |
0.0 | 0.5 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.0 | 0.0 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.7 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.2 | GO:0099738 | cell cortex region(GO:0099738) |
0.0 | 0.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 9.9 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.8 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.5 | GO:0031526 | brush border membrane(GO:0031526) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.3 | 135.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
8.1 | 105.4 | GO:0031386 | protein tag(GO:0031386) |
5.3 | 21.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
3.3 | 9.9 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
2.6 | 79.4 | GO:0070403 | NAD+ binding(GO:0070403) |
2.4 | 7.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
2.3 | 20.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
2.3 | 22.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
2.1 | 12.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.7 | 64.1 | GO:0005521 | lamin binding(GO:0005521) |
1.2 | 25.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
1.2 | 9.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
1.2 | 171.0 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
1.1 | 8.0 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
1.1 | 4.3 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
1.1 | 33.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
1.0 | 144.9 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.9 | 6.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.9 | 2.6 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
0.8 | 7.7 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.7 | 5.2 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.7 | 2.0 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
0.7 | 20.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.6 | 2.5 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
0.6 | 2.4 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.6 | 0.6 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.6 | 3.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 2.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.3 | 2.4 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.3 | 3.3 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.3 | 2.5 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.3 | 2.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.3 | 1.8 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.3 | 1.7 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 6.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 1.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.3 | 5.8 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 127.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 1.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 1.5 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.2 | 2.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 1.2 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
0.2 | 1.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.2 | 4.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 0.4 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
0.2 | 0.6 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.2 | 1.2 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 38.1 | GO:0001047 | core promoter binding(GO:0001047) |
0.2 | 0.6 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.2 | 3.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 1.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 0.9 | GO:0035276 | ethanol binding(GO:0035276) |
0.2 | 0.8 | GO:0031208 | POZ domain binding(GO:0031208) |
0.2 | 0.7 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 1.1 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.2 | 5.0 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 1.0 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.2 | 1.2 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.2 | 2.6 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.6 | GO:0005019 | platelet-derived growth factor beta-receptor activity(GO:0005019) |
0.1 | 1.5 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.1 | 0.6 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
0.1 | 0.6 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 0.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 1.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 1.5 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.4 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.1 | 1.4 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 1.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.4 | GO:0051499 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
0.1 | 0.9 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 0.5 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 2.1 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 34.1 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 1.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.5 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.8 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.9 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 13.9 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 0.3 | GO:0008441 | 3'(2'),5'-bisphosphate nucleotidase activity(GO:0008441) |
0.1 | 1.0 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 2.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.8 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.1 | 2.2 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.7 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 3.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 16.0 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 2.4 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 0.7 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 0.5 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.1 | 0.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 10.3 | GO:0005254 | chloride channel activity(GO:0005254) |
0.1 | 1.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 11.8 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 1.0 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.2 | GO:0030626 | U12 snRNA binding(GO:0030626) |
0.1 | 4.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 2.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 3.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 1.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.6 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.5 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.1 | 3.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 1.6 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.3 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) amine binding(GO:0043176) serotonin binding(GO:0051378) serotonin receptor activity(GO:0099589) |
0.1 | 0.8 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.5 | GO:0008865 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.1 | 0.3 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.1 | 0.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.8 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 1.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.0 | 1.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.3 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 2.2 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.0 | 8.2 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.1 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.0 | 0.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 1.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 1.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.3 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.4 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.2 | GO:0051800 | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 3.8 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.8 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.0 | 1.0 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.2 | GO:0015094 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.0 | 0.4 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 1.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.1 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.0 | 0.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.1 | GO:1902379 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
0.0 | 3.8 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.0 | 0.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.2 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.0 | 0.1 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
0.0 | 0.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.1 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
0.0 | 1.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.0 | 0.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.1 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.0 | 0.4 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) sequence-specific single stranded DNA binding(GO:0098847) |
0.0 | 0.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.5 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 62.0 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 1.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 2.2 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 0.4 | GO:0005539 | glycosaminoglycan binding(GO:0005539) heparin binding(GO:0008201) sulfur compound binding(GO:1901681) |
0.0 | 0.2 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.0 | 0.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.8 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.0 | 0.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.4 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 6.6 | GO:0016746 | transferase activity, transferring acyl groups(GO:0016746) |
0.0 | 0.7 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.0 | 0.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 1.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.3 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 0.1 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.0 | 0.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 1.0 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.5 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.4 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.0 | 1.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.5 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 1.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 3.3 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.2 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.0 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) aromatase activity(GO:0070330) |
0.0 | 0.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.1 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.0 | 0.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.6 | GO:0015144 | carbohydrate transmembrane transporter activity(GO:0015144) carbohydrate transporter activity(GO:1901476) |
0.0 | 0.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 1.1 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.3 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 55.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.6 | 106.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.5 | 63.6 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.4 | 13.5 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.3 | 1.7 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 10.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 4.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 15.5 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 3.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 1.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 11.5 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 1.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 9.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 6.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 8.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 5.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 3.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 5.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 6.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 4.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 2.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 5.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 4.0 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 1.1 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 1.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 1.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 1.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 1.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 1.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 2.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 1.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 4.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 1.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 2.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 2.9 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 1.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 2.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 1.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.7 | PID LKB1 PATHWAY | LKB1 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.1 | 191.9 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
8.2 | 736.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
1.3 | 5.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.7 | 38.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.5 | 29.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.4 | 20.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.2 | 7.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 3.5 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.2 | 2.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 12.5 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 1.7 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 1.0 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 2.4 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 5.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 12.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 2.3 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 25.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 1.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 2.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 3.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 4.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 2.7 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 1.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 1.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 1.0 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 1.1 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.1 | 1.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 1.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 1.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 2.2 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 1.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 2.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 1.0 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 1.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 2.8 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.5 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 1.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 1.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 1.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 1.7 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 0.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 3.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 1.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.9 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 1.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.3 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 0.7 | REACTOME TRANSCRIPTION | Genes involved in Transcription |
0.0 | 1.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 1.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 1.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.6 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.8 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |